BRUTTOMESSO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 8.560
AS - Asia 4.754
EU - Europa 2.213
AF - Africa 704
SA - Sud America 643
Continente sconosciuto - Info sul continente non disponibili 158
OC - Oceania 68
AN - Antartide 1
Totale 17.101
Nazione #
US - Stati Uniti d'America 8.084
SG - Singapore 1.353
VN - Vietnam 1.039
CN - Cina 847
IT - Italia 464
HK - Hong Kong 402
BR - Brasile 361
DE - Germania 291
FI - Finlandia 217
BD - Bangladesh 216
FR - Francia 171
IN - India 128
SE - Svezia 119
CA - Canada 106
GB - Regno Unito 106
PL - Polonia 101
NL - Olanda 76
IQ - Iraq 73
RU - Federazione Russa 73
TR - Turchia 64
UA - Ucraina 63
JP - Giappone 60
AR - Argentina 52
ES - Italia 48
ZA - Sudafrica 45
MX - Messico 41
PK - Pakistan 41
PH - Filippine 40
ID - Indonesia 37
JM - Giamaica 36
EC - Ecuador 35
IE - Irlanda 35
MY - Malesia 31
PE - Perù 31
CL - Cile 30
CO - Colombia 30
SA - Arabia Saudita 30
AL - Albania 29
CH - Svizzera 29
CI - Costa d'Avorio 29
AT - Austria 27
DZ - Algeria 27
CR - Costa Rica 26
EG - Egitto 26
AE - Emirati Arabi Uniti 25
AZ - Azerbaigian 25
KE - Kenya 25
NI - Nicaragua 24
GT - Guatemala 23
LV - Lettonia 23
UY - Uruguay 23
UZ - Uzbekistan 23
ET - Etiopia 22
HN - Honduras 22
JO - Giordania 22
RO - Romania 22
VE - Venezuela 22
BY - Bielorussia 21
GF - Guiana Francese 21
KG - Kirghizistan 21
MK - Macedonia 21
SO - Somalia 21
UG - Uganda 21
AU - Australia 20
GN - Guinea 20
IS - Islanda 20
PA - Panama 20
PY - Paraguay 20
TN - Tunisia 20
YT - Mayotte 20
BJ - Benin 19
KR - Corea 19
MA - Marocco 19
CV - Capo Verde 18
DK - Danimarca 18
PS - Palestinian Territory 18
AO - Angola 17
BO - Bolivia 17
CM - Camerun 17
GA - Gabon 17
GR - Grecia 17
IR - Iran 17
KZ - Kazakistan 17
LC - Santa Lucia 17
MD - Moldavia 17
ML - Mali 17
NP - Nepal 17
SI - Slovenia 17
BB - Barbados 16
BE - Belgio 16
BS - Bahamas 16
EE - Estonia 16
KH - Cambogia 16
MR - Mauritania 16
MU - Mauritius 16
RS - Serbia 16
TH - Thailandia 16
TJ - Tagikistan 16
TW - Taiwan 16
TZ - Tanzania 16
Totale 16.243
Città #
San Jose 923
Ashburn 860
Singapore 842
Fairfield 819
Chandler 516
Woodbridge 428
Houston 402
Hong Kong 365
Ann Arbor 333
Cambridge 313
Seattle 310
Ho Chi Minh City 294
Wilmington 268
Hanoi 257
Santa Clara 205
Beijing 180
Council Bluffs 163
Munich 147
Helsinki 134
Boardman 129
Los Angeles 123
Jacksonville 115
New York 108
Princeton 98
Padova 92
San Diego 87
Des Moines 76
Da Nang 72
Lauterbourg 71
Bytom 70
Medford 66
The Dalles 60
Dong Ket 54
Roxbury 47
Chicago 44
Guangzhou 43
Haiphong 39
Dallas 38
Frankfurt am Main 37
Tokyo 36
Buffalo 34
Nanjing 31
São Paulo 31
Modena 30
Milan 29
Abidjan 28
Dearborn 27
Orem 26
Shanghai 26
Dublin 25
Toronto 25
Atlanta 24
Managua 24
Montreal 24
Baku 23
Rome 23
Baghdad 22
London 22
Nairobi 22
Amman 21
Hải Dương 21
Johannesburg 21
Kampala 21
Shenyang 21
Tashkent 21
Warsaw 21
Montevideo 20
San José 20
Tirana 20
Addis Ababa 19
Bishkek 19
Conakry 19
Riga 19
Turku 19
Amsterdam 18
Cayenne 18
Lima 18
Minsk 18
Ninh Bình 18
Reykjavik 18
Castries 17
Cotonou 17
Guatemala City 17
Kingston 17
Phoenix 17
Stockholm 17
Bamako 16
Guayaquil 16
Libreville 16
Nassau 16
Nuremberg 16
Panama City 16
Biên Hòa 15
Brooklyn 15
Bến Tre 15
Chennai 15
Dakar 15
Denver 15
Dushanbe 15
Nanchang 15
Totale 10.488
Nome #
A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life 425
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 346
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 332
FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions 326
Closing the Loop 321
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 316
Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes 306
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 305
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 303
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance 294
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 292
Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile 291
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 287
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 280
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 279
Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pump 279
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 262
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 259
An Integrated Mobile Platform for Automated Data Collection and Real-Time Patient Monitoring in Diabetes Clinical Trials 254
Accuracy comparison between Dexcom G5 and Eversense sensors 252
Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes 249
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 246
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 245
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 242
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 241
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 235
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial 230
Real-Time Improvement of Continuous Glucose-Monitoring Accuracy - The smart sensor concept 227
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes 227
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 224
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor 224
Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship 218
Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP) 210
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 207
Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy 205
Multinational home use of closed-loop control is safe and effective 203
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP 202
Leucine and phenylalanine kinetics during mixed meal ingestion: a multiple tracer approach. 201
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 193
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery 191
Head to head accuracy comparison between two interstitial glucose sensors 191
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 190
A NEW TELEMEDICINE PLATFORM FOR CLINICAL TRIALS WITH AUTOMATIC SENSOR DATA GATHERING AND REAL TIME MONITORING 190
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 189
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown 188
Effects of wine intake on postprandial plasma amino acid and protein kinetics in type 1 diabetes 184
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy 183
A High-Fiber Diet Decreases Postabsorptive Protein Turnover but Does Not Alter Insulin Sensitivity in Men with Type 1 Diabetes Mellitus. 182
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy 181
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 180
MULTI-CENTER RANDOMIZED CROSS-OVER ITALIAN PEDIATRIC SUMMER CAMP: AP VS SAP IN 5-9 YEAR OLD CHILDREN 177
Effects of insulin and amino acid infusion on leucine and phenylalanine kinetics in type 1 diabetes. 177
Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting 175
Assessment of patient perceptions about web telemonitoring applied to artificial pancreas use at home 175
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 171
A comprehensive in-silico comparison of literature methods to adjust the meal insulin bolus accounting for continuous glucose monitoring rate of change 171
The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients 170
Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women 169
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes 164
Fasting and postmeal phenylalanine metabolism in mild type 2 diabetes. 164
La valutazione dei risultati: conoscenze, comportamenti, end-point terapeutici 160
Methods for Insulin Bolus Adjustment Based on the Continuous Glucose Monitoring Trend Arrows in Type 1 Diabetes: Performance and Safety Assessment in an In Silico Clinical Trial 158
Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). 155
Reduction of Hyper- and Hypoglycemia during Two Months with a Wearable Artificial Pancreas from Dinner to Breakfast in Patients with Type 1 Diabetes 155
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis 155
Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care 153
The use of degrees of certainty to evaluate knowledge 153
Lipoatrophy Induced by Subcutaneous Insulin Infusion: Ultrastructural Analysis and Gene Expression Profiling 153
Assessment and comparison of the measurement error components of Dexcom G5 Mobile and Eversense continuous glucose monitoring systems 151
THE SOCIAL ACCEPTANCE OF FUTURE ARTIFICIAL PANCREAS TECHNOLOGY: PARENTS' PERCEPTIONS OF PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) 148
Artificial pancreas: A review of fundamentals and inpatient and outpatient studies 142
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 141
Artificial Pancreas Improves Glycemic Control in a Multi-night Multicenter Outpatient/Home Study of Patients with T1D 136
HbA(1c) improvement with less hypoglycaemia in patients with type 1 diabetes wearing an artificial pancreas for two months from dinner to breakfast 130
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type I diabetic patients: A multicenter randomized crossover trial 128
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 126
The Multi-Modular Model Predictive Control-to-Range (MPC2R) Allows Simultaneous Improvement in Safety and Efficacy of Closed-Loop Insulin Delivery in Type 1 Diabetes (T1D) 117
La terapia insulinica sottocutanea continua in Italia. Seconda indagine nazionale 115
Psychological aspects of evening and night closed-loop insulin delivery under free living conditions: a 2 months cross-over trial 113
IMPROVEMENT OF THE CHILDREN POPULATION INCLUDED INTO THE UVA/PADOVA TYPE 1 DIABETES SIMULATOR 108
Personalized Subcutaneous Model-Predictive Closed-Loop Control of T1DM: Pilot Studies in the USA and Italy 108
null 104
Protein degradation and synthesis measured with multiple amino acid tracers in post-absorptive and protein-anabolic conditions. 92
Totale 17.101
Categoria #
all - tutte 48.497
article - articoli 40.696
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 466
Totale 89.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.013 0 0 134 70 84 110 37 127 112 25 68 246
2022/2023946 178 108 29 120 154 126 7 63 104 10 33 14
2023/2024424 16 71 67 42 31 44 14 12 9 32 43 43
2024/20252.069 16 201 115 94 282 78 133 191 160 83 277 439
2025/20268.136 328 574 938 1.176 737 280 1.510 616 869 480 354 274
2026/2027954 315 364 275 0 0 0 0 0 0 0 0 0
Totale 17.101